Correlation analysis between single-nucleotide polymorphism and expression arrays in gliomas identifies potentially relevant target genes

Cancer Research

Volumn 69, Issue 4, 2009, Pages 1596-1603

  Kotliarov, Yuri ^a   Kotliarova, Svetlana ^a,b   Charong, Nurdina ^a   Li, Aiguo ^a   Walling, Jennifer ^a   Aquilanti, Elisa ^a   Ahn, Susie ^a   Steed, Mary Ellen ^a   Su, Qin ^a   Center, Angela ^a   Zenklusen, Jean C ^a   Fine, Howard A ^a,b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

STROMAL CELL DERIVED FACTOR 1;

ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GENE TARGETING; GENOMICS; GLIOMA; HUMAN; MAJOR CLINICAL STUDY; MUTATION; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; BRAIN NEOPLASMS; CHILD; DNA METHYLATION; DNA, NEOPLASM; GLIOMA; HUMANS; LOSS OF HETEROZYGOSITY; MUTATION; NEOPLASM PROTEINS; NERVE TISSUE PROTEINS; NUCLEIC ACID HYBRIDIZATION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 60549087374     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-08-2496     Document Type: Article

References (19)

1. Cancer Statistics Branch N, NIH. Cancer survival rates. In: Harras A, editor. Cancer: rates and risks. Washington (DC): U.S. Department of Health and Human Services, NIH; 1996. p. 28-34.
2. Hartmann C, Mueller W, von Deimling A. Pathology and molecular genetics of oligodendroglial tumors. J Mol Med 2004;82:638-55.
3. Reifenberger G, Collins VP. Pathology and molecular genetics of astrocytic gliomas. J Mol Med 2004;82:656-70.
4. Raizer JJ. HER1/EGFR tyrosine kinase inhibitors for the treatment of glioblastoma multiforme. J Neurooncol 2005;74:77-86.
5. Haas-Kogan DA, Prados MD, Tihan T, et al. Epidermal growth factor receptor, protein kinase B/Akt, and glioma response to erlotinib. J Natl Cancer Inst 2005;97:880-7.
6. Kotliarov Y, Steed ME, Christopher N, et al. High-resolution global genomic survey of 178 gliomas reveals novel regions of copy number alteration and allelic imbalances. Cancer Res 2006;66:9428-36.
7. Matsuzaki H, Dong S, Loi H, et al. Genotyping over 100,000 SNPs on a pair of oligonucleotide arrays. Nat Methods 2004;1:109-11.
8. Huang J, Wei W, Zhang J, et al. Whole genome DNA copy number changes identified by high density oligonucleotide arrays. Hum Genomics 2004;1:287-99.
9. Miller CL, Diglisic S, Leister F, Webster M, Yolken RH. Evaluating RNA status for RT-PCR in extracts of postmortem human brain tissue. Biotechniques 2004;36:628-33.
10. Lipshutz RJ, Fodor SP, Gingeras TR, Lockhart DJ. High density synthetic oligonucleotide arrays. Nat Genet 1999;21:20-4.
11. Seo J, Bakay M, Chen YW, Hilmer S, Shneiderman B, Hoffman EP. Interactively optimizing signal-to-noise ratios in expression profiling: project-specific algorithm selection and detection P value weighting in Affymetrix microarrays. Bioinformatics 2004;20:2534-44.
12. Seo J, Gordish-Dressman H, Hoffman EP. An interactive power analysis tool for microarray hypothesis testing and generation. Bioinformatics 2006;22:808-14.
13. Kotliarova S, Pastorino S, Kovell LC, et al. Glycogen synthase kinase-3 inhibition induces glioma cell death through c-MYC, nuclear factor-κB, and glucose regulation. Cancer Res 2008;68:6643-51.
14. Nigro JM, Misra A, Zhang L, et al. Integrated array-comparative genomic hybridization and expression array profiles identify clinically relevant molecular subtypes of glioblastoma. Cancer Res 2005;65:1678-86.
15. Dehan E, Ben-Dor A, Liao W, et al. Chromosomal aberrations and gene expression profiles in non-small cell lung cancer. Lung Cancer 2007;56:175-84.
16. Robinson PN, Bohme U, Lopez R, Mundlos S, Nurnberg P. Gene-Ontology analysis reveals association of tissue-specific 5′ CpG-island genes with development and embryogenesis. Hum Mol Genet 2004;13:1969-78.
17. Fox BP, Kandpal RP. Transcriptional silencing of EphB6 receptor tyrosine kinase in invasive breast carcinoma cells and detection of methylated promoter by methylation specific PCR. Biochem Biophys Res Commun 2006;340:268-76.
18. Hafner C, Bataille F, Meyer S, et al. Loss of EphB6 expression in metastatic melanoma. Int J Oncol 2003;23:1553-9.
19. Tang XX, Robinson ME, Riceberg JS, et al. Favorable neuroblastoma genes and molecular therapeutics of neuroblastoma. Clin Cancer Res 2004;10:5837-44.